Skye Bioscience, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Skye Bioscience, Inc. (SKYE) had Deferred Tax Assets, Operating Loss Carryforwards of $50.22 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $50.22M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $41.63M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $40.90M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $30.65M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $50.22M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $41.63M 10-K · filed 2026-03-10 | |
| 2023-12-31 | $40.90M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $30.65M 10-K · filed 2024-03-22 | |
| 2021-12-31 | $8.89M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $7.68M 10-K · filed 2022-03-28 | |
| 2019-12-31 | $6.43M 10-K · filed 2021-03-02 | |
| 2018-12-31 | $5.10M 10-K · filed 2020-03-23 | |
| 2017-12-31 | $3.70M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $4.06M 10-K · filed 2018-03-19 | |
| 2015-12-31 | $1.87M 10-K · filed 2017-03-10 | |
| 2014-12-31 | $1.07M 10-K · filed 2016-03-21 | $989.54K 10-K · filed 2015-03-27 |
| 2013-04-30 | $1.38K 10-Q · filed 2013-06-27 | |
| 2012-10-31 | $1.62K 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |